The Centers for Medicare and Medicaid Services (CMS) posted a final National Coverage Determination (NCD) for Pre-exposure Prophylaxis (PrEP) Using Antiretroviral Drugs to Prevent Human Immunodeficiency Virus (HIV) Infection.
Under this NCD, Medicare will cover oral and injectable forms of PrEP and other related services to prevent HIV without cost-sharing (i.e., deductibles or co-pays) under Medicare Part B, expanding access to these preventive medications.
Information on Medicare coverage of PrEP for HIV prevention can be found on this fact sheet and on this consumer summary.
